Skyrizi and Rinvoq sales are pushing AbbVie's sales higher. UnitedHealth Group raised its full-year guidance and is rebounding from a disastrous 2025.
CVS Health has improved its financial results this year. The company's efforts could allow it to maintain that momentum.
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)-- #TRUEMETRIX--Trividia Health, Inc., announced today that it's TRUE METRIX® Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on C
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Y Intercept Hong Kong Ltd acquired a new stake in shares of CVS Health Corporation (NYSE: CVS) in the second quarter, according to the company in its most recent disclosure with the Securities and Exc

CVS Health: Undervalued And Ripe For Growth

08:00am, Monday, 03'rd Nov 2025
CVS Health offers a compelling value and income opportunity, trading at a forward P/E under 12 with a 3.4% dividend yield. It delivered strong Q3 results, driven by Aetna's insurance segment and momen
WOONSOCKET, R.I. , Oct. 31, 2025 /PRNewswire/ -- CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is boosti
I present a diversified selection of high-yield dividend stocks with strong income and growth potential, including CVX, VZ, MO, ARCC, and others. Each company was selected for sustainable dividends, a
UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size
CVS Health Corp (NYSE:CVS) reported third quarter 2025 financial results on Wednesday, posting both revenue and adjusted earnings per share (EPS) above Wall Street expectations. For the quarter, CVS r
The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street es
CVS Health Corporation ( CVS ) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants Larry McGrath - Executive VP, Chief Strategy Officer & Chief Strategic Advisor to the CEO J. Joyn
CVS Health Corp (NYSE:CVS) on Wednesday reported better-than-expected third-quarter earnings and raised its annual guidance.
CVS reported Q3 financials showing it beat on earnings and revenue, which resulted in strong forward guidance.
CVS shares slip even though Q3 earnings and revenues beat estimates, with the company boosting its 2025 EPS outlook.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE